We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

101 hedge funds and large institutions have $166M invested in AVEO Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 36 increasing their positions, 16 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

285% more call options, than puts

Call options by funds: $21.7M | Put options by funds: $5.64M

125% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 16

44% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 16

39% more capital invested

Capital invested by funds: $119M → $166M (+$46.9M)

7% more funds holding

Funds holding: 94 → 101 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
101
Holders Change
+7
Holders Change %
+7.45%
% of All Funds
2.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
36
Reduced
16
Closed
16
Calls
$21.7M
Puts
$5.64M
Net Calls
+$16M
Net Calls Change
+$4.45M

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$2.35M
2
Citadel Advisors
Citadel Advisors
Florida
+$1.07M
3
KCM
Kennedy Capital Management
Missouri
+$899K
4
FI
Fosun International
China
+$805K
5
BlackRock
BlackRock
New York
+$368K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$11.4M
2
PC
Polar Capital
United Kingdom
-$8.88M
3
Millennium Management
Millennium Management
New York
-$5.03M
4
PA
Perceptive Advisors
New York
-$4.27M
5
Group One Trading
Group One Trading
Illinois
-$644K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
101
Perceptive Advisors
New York
– -$4.27M -189,119 Closed
Group One Trading
102
Group One Trading
Illinois
– -$644K -25,048 Closed
PM
103
Prosight Management
Texas
– -$337K -14,907 Closed
QIM
104
Quantitative Investment Management
Virginia
– -$121K -5,380 Closed
SSA
105
Schonfeld Strategic Advisors
New York
– -$113K -5,000 Closed
FNBT
106
FineMark National Bank & Trust
Florida
– -$90K -4,000 Closed
CS
107
Credit Suisse
Switzerland
– -$65K -2,840 Closed
ARTA
108
A.R.T. Advisors
New York
– -$61K -2,726 Closed
HF
109
HRT Financial
New York
– -$46K -2,048 Closed
AB
110
Amalgamated Bank
New York
– -$33K -1,470 Closed
RJFSA
111
Raymond James Financial Services Advisors
Florida
– -$26K -1,152 Closed
SG Americas Securities
112
SG Americas Securities
New York
– -$25K -1,098 Closed
CIBC Private Wealth Group
113
CIBC Private Wealth Group
Georgia
– -$5K -200 Closed
PIA
114
Piedmont Investment Advisors
North Carolina
– -$4K -177 Closed
KF
115
Krilogy Financial
Missouri
– +$257 +10 New
1 2 3 4
5

AVEO Hedge Fund Activity: Q3 2018 in Review

101 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q3 2018, worth a combined $166M — up 39% from $119M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new AVEO positions and 16 closed out — a net gain of 7 holders — while 36 added to existing stakes and 16 trimmed.

The largest buyer was NEA Management Company, adding an estimated $2.35M. The largest seller was RA Capital Management, exiting entirely with an estimated $11.4M sold.

  • 101 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q3 2018, up from 94 in Q2 2018.
  • Funds reported $166M of AVEO Pharmaceuticals, Inc. stock for Q3 2018, up 39% quarter-over-quarter.
  • 23 funds opened new AVEO Pharmaceuticals, Inc. positions in Q3 2018 and 16 closed out, a net change of +7 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q3 2018 was NEA Management Company, an estimated $2.35M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q3 2018 was RA Capital Management, an estimated $11.4M sold.

Based on aggregated 13F filings for Q3 2018.